In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRN Support For NAD At 10 Years: 250 Ad Claim Reviews, Better Industry Image

This article was originally published in The Tan Sheet

Executive Summary

"We hoped that it would have legs and it would last," says CRN President and CEO Steve Mister. "We thought, 'If it makes a difference, if we feel like we actually are doing something of value for the industry, we'll keep it up'."

Advertisement

Related Content

'Enhanced Brain Function' Supplement Sales Only A Memory After NAD Review
Opiate Addiction Remedy Claims Could Face FTC Substantiation Test
Energizing Jelly Beans Deliver 'Sweet Side' But Not 'Faster Run' – NAD
NAD: Anti-Aging Claims ‘Muted A Bit,’ But Vigilance Remains High
CRN Grants $500K To NAD For Increased Dietary Supplement Monitoring

Topics

Advertisement
UsernamePublicRestriction

Register

RS108940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel